Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
132
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Protagonist Therapeutics Inc market cap is $7.92B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Protagonist Therapeutics Inc 52 week high is $160.81 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Protagonist Therapeutics Inc 52 week low is $77.00 as of November 22, 2026.
Protagonist Therapeutics Inc stock price today is $121.40.
Protagonist Therapeutics Inc stock price yesterday was $124.02.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Protagonist Therapeutics Inc's P/E ratio is 25.71.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Protagonist Therapeutics Inc P/B ratio is 7.2975.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Protagonist Therapeutics Inc 50-day moving average is $138.14.